4 results
DEF 14A
MLYS
Mineralys Therapeutics Inc
9 Apr 24
Definitive proxy
7:15am
, and reputational risk.
The audit committee reviews information regarding liquidity and operations and oversees our management of financial risks. Periodically
DRS/A
MLYS
Mineralys Therapeutics Inc
29 Dec 22
Draft registration statement (amended)
12:00am
material risk, including operations, finance, legal, regulatory, strategic and reputational risk.
The audit committee reviews information regarding
DRS/A
MLYS
Mineralys Therapeutics Inc
7 Dec 22
Draft registration statement (amended)
12:00am
, regulatory, strategic and reputational risk.
The audit committee reviews information regarding liquidity and operations and oversees our management
DRS
MLYS
Mineralys Therapeutics Inc
4 Nov 22
Draft registration statement
12:00am
, finance, legal, regulatory, strategic and reputational risk.
The audit committee reviews information regarding liquidity and operations, and oversees
- Prev
- 1
- Next